[Management of hyperlipidemia in the elderly]

Area of Science:

• Gerontology
• Endocrinology
• Cardiovascular Medicine

Context:

• Serum lipid profiles, including cholesterol and triglycerides, exhibit age-related changes, typically peaking in middle age and decreasing in older adulthood.
• These alterations are partially influenced by shifts in endogenous sex hormones, particularly in women.
• The prevalence of dyslipidemia remains consistent between middle-aged and elderly populations.

Purpose:

• To explore the differential impact of age on lipid metabolism and dyslipidemia.
• To evaluate the current treatment strategies for hyperlipidemia across different age groups.
• To investigate the age-specific benefits of hyperlipidemia treatment, particularly statin therapy.

Summary:

• Serum cholesterol and triglyceride levels increase until middle age and then decline in old age, influenced by sex hormone changes.
• Dyslipidemia incidence does not significantly differ between middle-aged and elderly individuals.
• Current treatment approaches for hyperlipidemia vary by age, reflecting a perceived decline in treatment benefit with advanced age.

Impact:

• Statin treatment shows benefit in younger-elderly individuals but may offer limited advantages in the oldest-old.
• The necessity of hyperlipidemia treatment in the oldest-old requires further investigation through prospective studies.
• Findings suggest a need for age-stratified treatment guidelines for dyslipidemia management.